FedEx’s hubs at Guangzhou Baiyun International Airport, China, and Kansai International Airport, Japan, have been awarded with the prestigious Center of Excellence for Independent Validators (CEIV) in Pharmaceutical Logistics certification, strengthening the company’s pharmaceutical logistics business.
The CEIV certification from the International Air Transport Association (IATA) ensures the highest standards in the handling and transportation of time- and temperature-sensitive healthcare products such as pharmaceutical products and vaccines across air networks.
“Healthcare innovation demands smarter, faster and more resilient supply chains,” said Kawal Preet, president, Asia Pacific, FedEx. “As Asia Pacific rapidly emerges as a global hub for clinical trials and biopharma manufacturing, the need for secure, compliant and technology-enabled logistics is more important than ever.
“Our proven expertise in building intelligent cold chain solutions is designed to protect product integrity, ensure regulatory compliance and deliver peace of mind to our customers.
“By combining our global network with AI-driven logistics and real-time monitoring, FedEx is helping healthcare and life sciences companies unlock speed, scale and reliability, supporting the next wave of healthcare innovation across the region.”
The certifications at these two airport hubs are part of a broader FedEx initiative to expand CEIV-compliant infrastructure globally. As of May 2025, a total of 19 FedEx facilities worldwide, including key locations in Europe and the Americas, will operate under the CEIV Pharma quality framework.
Read more about the growth of healthcare logistics in the June 2025 issue of Parcel and Postal Technology International – coming soon!